4//SEC Filing
ZIOPHARM ONCOLOGY INC 4
Accession 0001209191-17-000982
$TCRTCIK 0001107421operating
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:39 PM ET
Size
10.1 KB
Accession
0001209191-17-000982
Insider Transaction Report
Form 4
BELBEL CAESAR J
EVP, Chief Legal Officer & Sec
Transactions
- Award
Common Stock
2016-12-30+94,350→ 211,884 total - Tax Payment
Common Stock
2016-12-31$5.35/sh−21,667$115,918→ 190,217 total
Footnotes (2)
- [F1]31,450 shares vest on each of 12/30/2017, 12/30/2018 and 12/30/2019.
- [F2]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001107421
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:39 PM ET
- Size
- 10.1 KB